Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

Anna Heath; Petros Pechlivanoglou

doi:10.1177/0272989x211072858

Loading next page...

References (62)

Eline Krijkamp, F. Alarid-Escudero, E. Enns, Hawre Jalal, M. Hunink, M. Hunink, P. Pechlivanoglou (2018)
Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial
Medical Decision Making, 38
( HeathA BaioG . Calculating the expected value of sample information using efficient nested Monte Carlo: a tutorial. Value in Health, 2018;21(11):1299-1304.30442277)
HeathA BaioG . Calculating the expected value of sample information using efficient nested Monte Carlo: a tutorial. Value in Health, 2018;21(11):1299-1304.30442277
HeathA BaioG . Calculating the expected value of sample information using efficient nested Monte Carlo: a tutorial. Value in Health, 2018;21(11):1299-1304.30442277, HeathA BaioG . Calculating the expected value of sample information using efficient nested Monte Carlo: a tutorial. Value in Health, 2018;21(11):1299-1304.30442277
Anna Heath, I. Manolopoulou, G. Baio (2015)
Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation
Statistics in Medicine, 35
A. Agustí (2014)
The path to personalised medicine in COPD
Thorax, 69
K. Claxton (1999)
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Journal of health economics, 18 3
( FenwickE ClaxtonK SculpherM . The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008;28(1):21–32.18263559)
FenwickE ClaxtonK SculpherM . The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008;28(1):21–32.18263559
FenwickE ClaxtonK SculpherM . The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008;28(1):21–32.18263559, FenwickE ClaxtonK SculpherM . The value of implementation and the value of information: combined and uneven development. Med Decis Making. 2008;28(1):21–32.18263559
( KrijkampE Alarid-EscuderoF EnnsE JalalH HuninkM PechlivanoglouP . Microsimulation modeling for health decision sciences using r: a tutorial. Med Decis Making. 2018;38(3):400–22.)
KrijkampE Alarid-EscuderoF EnnsE JalalH HuninkM PechlivanoglouP . Microsimulation modeling for health decision sciences using r: a tutorial. Med Decis Making. 2018;38(3):400–22.
KrijkampE Alarid-EscuderoF EnnsE JalalH HuninkM PechlivanoglouP . Microsimulation modeling for health decision sciences using r: a tutorial. Med Decis Making. 2018;38(3):400–22., KrijkampE Alarid-EscuderoF EnnsE JalalH HuninkM PechlivanoglouP . Microsimulation modeling for health decision sciences using r: a tutorial. Med Decis Making. 2018;38(3):400–22.
Morris Gottlieb, Robert Schlaifer (1960)
Probability And Statistics For Business Decisions
( CoyleD BuxtonM O’BrienB . Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12(5):421–7.)
CoyleD BuxtonM O’BrienB . Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12(5):421–7.
CoyleD BuxtonM O’BrienB . Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12(5):421–7., CoyleD BuxtonM O’BrienB . Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria. Health Econ. 2003;12(5):421–7.
( BriggsA WeinsteinM FenwickE KarnonJ SculpherM PaltielA ; ISPOR-SMDM Modeling Good Research Practices Task Force et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835–42.)
BriggsA WeinsteinM FenwickE KarnonJ SculpherM PaltielA ; ISPOR-SMDM Modeling Good Research Practices Task Force et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835–42.
BriggsA WeinsteinM FenwickE KarnonJ SculpherM PaltielA ; ISPOR-SMDM Modeling Good Research Practices Task Force et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835–42., BriggsA WeinsteinM FenwickE KarnonJ SculpherM PaltielA ; ISPOR-SMDM Modeling Good Research Practices Task Force et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health. 2012;15(6):835–42.
( StinnettA MullahyJ . Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68–80.9566468)
StinnettA MullahyJ . Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68–80.9566468
StinnettA MullahyJ . Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68–80.9566468, StinnettA MullahyJ . Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68–80.9566468
K. Claxton, P. Neumann, Sally Araki, M. Weinstein (2001)
BAYESIAN VALUE-OF-INFORMATION ANALYSIS
International Journal of Technology Assessment in Health Care, 17
E. Fenwick, K. Claxton, M. Sculpher (2008)
The Value of Implementation and the Value of Information: Combined and Uneven Development
Medical Decision Making, 28
James Felli, Gordon Hazen (1998)
Sensitivity Analysis and the Expected Value of Perfect Information
Medical Decision Making, 18
( MinelliC BaioG . Value of information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9):e1001882.26418866)
MinelliC BaioG . Value of information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9):e1001882.26418866
MinelliC BaioG . Value of information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9):e1001882.26418866, MinelliC BaioG . Value of information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9):e1001882.26418866
A. Stinnett, J. Mullahy (1998)
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Health Economics Evaluation Methods eJournal
K. Claxton, M. Sculpher, Chris McCabe, Andrew Briggs, Ron Akehurst, Martin Buxton, John Brazier, Tony O'Hagan (2005)
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
Health economics, 14 4
( AgustiA . The path to personalised medicine in copd. Thorax. 2014;69(9):857–64.)
AgustiA . The path to personalised medicine in copd. Thorax. 2014;69(9):857–64.
AgustiA . The path to personalised medicine in copd. Thorax. 2014;69(9):857–64., AgustiA . The path to personalised medicine in copd. Thorax. 2014;69(9):857–64.
( RaiffaH SchlaiferH . Applied Statistical Decision Theory. Boston: Harvard University Press; 1961.)
RaiffaH SchlaiferH . Applied Statistical Decision Theory. Boston: Harvard University Press; 1961.
RaiffaH SchlaiferH . Applied Statistical Decision Theory. Boston: Harvard University Press; 1961., RaiffaH SchlaiferH . Applied Statistical Decision Theory. Boston: Harvard University Press; 1961.
( ClaxtonK SculpherM McCabeC , et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339–47.)
ClaxtonK SculpherM McCabeC , et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339–47.
ClaxtonK SculpherM McCabeC , et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339–47., ClaxtonK SculpherM McCabeC , et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339–47.
( SculpherMJ ClaxtonK DrummondM McCabeC . Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15(7):677–87.)
SculpherMJ ClaxtonK DrummondM McCabeC . Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15(7):677–87.
SculpherMJ ClaxtonK DrummondM McCabeC . Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15(7):677–87., SculpherMJ ClaxtonK DrummondM McCabeC . Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15(7):677–87.
R. Iman, W. Conover (1982)
A distribution-free approach to inducing rank correlation among input variables
Communications in Statistics - Simulation and Computation, 11
Sarah Jackson, J. Chester (2015)
Personalised cancer medicine
International Journal of Cancer, 137
( FelliJ HazenG . Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95–109.9456214)
FelliJ HazenG . Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95–109.9456214
FelliJ HazenG . Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95–109.9456214, FelliJ HazenG . Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95–109.9456214
( JacksonS ChesterJ . Personalised cancer medicine. Int J Cancer. 2015;137(2):262–6.)
JacksonS ChesterJ . Personalised cancer medicine. Int J Cancer. 2015;137(2):262–6.
JacksonS ChesterJ . Personalised cancer medicine. Int J Cancer. 2015;137(2):262–6., JacksonS ChesterJ . Personalised cancer medicine. Int J Cancer. 2015;137(2):262–6.
M. Sculpher, K. Claxton, M. Drummond, C. McCabe (2006)
Whither trial-based economic evaluation for health care decision making?
Health economics, 15 7
C. Minelli, G. Baio (2015)
Value of Information: A Tool to Improve Research Prioritization and Reduce Waste
PLoS Medicine, 12
( SculpherM . Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):799–806.18767899)
SculpherM . Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):799–806.18767899
SculpherM . Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):799–806.18767899, SculpherM . Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):799–806.18767899
D. Coyle, M. Buxton, B. O'brien (2003)
Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.
Health economics, 12 5
P. Minton, H. Raiffa, Robert Schlaifer (1961)
Applied Statistical Decision Theory.
American Mathematical Monthly, 69
Anna Heath, G. Baio (2017)
Calculating the Expected Value of Sample Information Using Efficient Nested Monte Carlo: A Tutorial.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 21 11
M. Espinoza, A. Manca, K. Claxton, M. Sculpher (2014)
The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis
Medical Decision Making, 34
( IsaacsJ FerraccioliG . The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4–7.21068091)
IsaacsJ FerraccioliG . The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4–7.21068091
IsaacsJ FerraccioliG . The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4–7.21068091, IsaacsJ FerraccioliG . The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4–7.21068091
PhD Ades, G. Lu, PhD Claxton (2004)
Expected Value of Sample Information Calculations in Medical Decision Modeling
Medical Decision Making, 24
( ImanR ConoverW . A distribution-free approach to inducing rank correlation among input variables. Commun Stat Simulat Comput. 1982;11(3):311–34.)
ImanR ConoverW . A distribution-free approach to inducing rank correlation among input variables. Commun Stat Simulat Comput. 1982;11(3):311–34.
ImanR ConoverW . A distribution-free approach to inducing rank correlation among input variables. Commun Stat Simulat Comput. 1982;11(3):311–34., ImanR ConoverW . A distribution-free approach to inducing rank correlation among input variables. Commun Stat Simulat Comput. 1982;11(3):311–34.
K. Claxton, K. Claxton (1999)
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals.
Health economics, 8 3
( EspinozaM MancaA ClaxtonK SculpherM . The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34(8):951–64.)
EspinozaM MancaA ClaxtonK SculpherM . The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34(8):951–64.
EspinozaM MancaA ClaxtonK SculpherM . The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34(8):951–64., EspinozaM MancaA ClaxtonK SculpherM . The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34(8):951–64.
SimJoint: Simulate Joint Distribution
( RuscioJ KaczetowW . Simulating multivariate nonnormal data using an iterative algorithm. Multivariate Behav Res. 2008;43(3):355–81.)
RuscioJ KaczetowW . Simulating multivariate nonnormal data using an iterative algorithm. Multivariate Behav Res. 2008;43(3):355–81.
RuscioJ KaczetowW . Simulating multivariate nonnormal data using an iterative algorithm. Multivariate Behav Res. 2008;43(3):355–81., RuscioJ KaczetowW . Simulating multivariate nonnormal data using an iterative algorithm. Multivariate Behav Res. 2008;43(3):355–81.
( WillanA EckermannS . Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ. 2010;19(5):549–61.)
WillanA EckermannS . Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ. 2010;19(5):549–61.
WillanA EckermannS . Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ. 2010;19(5):549–61., WillanA EckermannS . Optimal clinical trial design using value of information methods with imperfect implementation. Health Econ. 2010;19(5):549–61.
( SchlaiferR . Probability and Statistics for Business Decisions. New York: McGraw-Hill; 1959.)
SchlaiferR . Probability and Statistics for Business Decisions. New York: McGraw-Hill; 1959.
SchlaiferR . Probability and Statistics for Business Decisions. New York: McGraw-Hill; 1959., SchlaiferR . Probability and Statistics for Business Decisions. New York: McGraw-Hill; 1959.
( LiuCW . SimJoint: Simulate Joint Distribution. R package version 0.3.7. 2020.)
LiuCW . SimJoint: Simulate Joint Distribution. R package version 0.3.7. 2020.
LiuCW . SimJoint: Simulate Joint Distribution. R package version 0.3.7. 2020., LiuCW . SimJoint: Simulate Joint Distribution. R package version 0.3.7. 2020.
N. Menzies (2016)
An Efficient Estimator for the Expected Value of Sample Information
Medical Decision Making, 36
A. Basu, D. Meltzer (2007)
Value of Information on Preference Heterogeneity and Individualized Care
Medical Decision Making, 27
( KoffijbergH RotheryC ChalkidouK GruttersJ . Value of information choices that influence estimates: a systematic review of prevailing considerations. Med Decis Making. 2018;38(7):888–900.30188244)
KoffijbergH RotheryC ChalkidouK GruttersJ . Value of information choices that influence estimates: a systematic review of prevailing considerations. Med Decis Making. 2018;38(7):888–900.30188244
KoffijbergH RotheryC ChalkidouK GruttersJ . Value of information choices that influence estimates: a systematic review of prevailing considerations. Med Decis Making. 2018;38(7):888–900.30188244, KoffijbergH RotheryC ChalkidouK GruttersJ . Value of information choices that influence estimates: a systematic review of prevailing considerations. Med Decis Making. 2018;38(7):888–900.30188244
J. Isaacs, G. Ferraccioli (2010)
The need for personalised medicine for rheumatoid arthritis
Annals of the Rheumatic Diseases, 70
(2020)
SimJoint: Simulate Joint Distribution. R package version 0.3.7
( MenziesN . An efficient estimator for the expected value of sample information. Med Decis Making. 2016;36(3):308–20.)
MenziesN . An efficient estimator for the expected value of sample information. Med Decis Making. 2016;36(3):308–20.
MenziesN . An efficient estimator for the expected value of sample information. Med Decis Making. 2016;36(3):308–20., MenziesN . An efficient estimator for the expected value of sample information. Med Decis Making. 2016;36(3):308–20.
A. Willan, A. Briggs, J. Hoch (2004)
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
Health economics, 13 5
M. Strong, J. Oakley, A. Brennan (2013)
Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample
Medical Decision Making, 34
H. Koffijberg, C. Rothery, K. Chalkidou, J. Grutters (2018)
Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations
Medical Decision Making, 38
( BasuA MeltzerD . Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2):112–27.)
BasuA MeltzerD . Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2):112–27.
BasuA MeltzerD . Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2):112–27., BasuA MeltzerD . Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2):112–27.
M. Strong, J. Oakley, A. Brennan, Penny Breeze (2015)
Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample
Medical Decision Making, 35
A. Willan, S. Eckermann (2009)
Optimal clinical trial design using value of information methods with imperfect implementation.
Health economics, 19 5
( AdesA LuG ClaxtonK . Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24:207–27.)
AdesA LuG ClaxtonK . Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24:207–27.
AdesA LuG ClaxtonK . Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24:207–27., AdesA LuG ClaxtonK . Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24:207–27.
( StrongM OakleyJ BrennanA BreezeP . Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast nonparametric regression-based method. Med Decis Making. 2015;35(5):570–83.)
StrongM OakleyJ BrennanA BreezeP . Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast nonparametric regression-based method. Med Decis Making. 2015;35(5):570–83.
StrongM OakleyJ BrennanA BreezeP . Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast nonparametric regression-based method. Med Decis Making. 2015;35(5):570–83., StrongM OakleyJ BrennanA BreezeP . Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast nonparametric regression-based method. Med Decis Making. 2015;35(5):570–83.
Andrew Briggs, Dphil, Milton Weinstein, Elisabeth Fenwick, J. Karnon, M. Sculpher, A. Paltiel
Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern
M. Sculpher (2012)
Subgroups and Heterogeneity in Cost-Effectiveness Analysis
PharmacoEconomics, 26
( JalalH Alarid-EscuderoF . A Gaussian approximation approach for value of information analysis. Med Decis Making. 2017;38(3):174–88.)
JalalH Alarid-EscuderoF . A Gaussian approximation approach for value of information analysis. Med Decis Making. 2017;38(3):174–88.
JalalH Alarid-EscuderoF . A Gaussian approximation approach for value of information analysis. Med Decis Making. 2017;38(3):174–88., JalalH Alarid-EscuderoF . A Gaussian approximation approach for value of information analysis. Med Decis Making. 2017;38(3):174–88.
Anna Heath, M. Hunink, Eline Krijkamp, P. Pechlivanoglou (2021)
Prioritisation and design of clinical trials
European Journal of Epidemiology, 36
Hawre Jalal, F. Alarid-Escudero (2017)
A Gaussian Approximation Approach for Value of Information Analysis
Medical Decision Making, 38
John Ruscio, Walter Kaczetow (2008)
Simulating Multivariate Nonnormal Data Using an Iterative Algorithm
Multivariate Behavioral Research, 43

Publisher: SAGE
Copyright: © The Author(s) 2022
ISSN: 0272-989X
eISSN: 1552-681X
DOI: 10.1177/0272989x211072858
Publisher site: See Article on Publisher Site

Abstract

BackgroundClinical care is moving from a “one size fits all” approach to a setting in which treatment decisions are based on individual treatment response, needs, preferences, and risk. Research into personalized treatment strategies aims to discover currently unknown markers that identify individuals who would benefit from treatments that are nonoptimal at the population level. Before investing in research to identify these markers, it is important to assess whether such research has the potential to generate value. Thus, this article aims to develop a framework to prioritize research into the development of new personalized treatment strategies by creating a set of measures that assess the value of personalizing care based on a set of unknown patient characteristics.MethodsGeneralizing ideas from the value of heterogeneity framework, we demonstrate 3 measures that assess the value of developing personalized treatment strategies. The first measure identifies the potential value of personalizing medicine within a given disease area. The next 2 measures highlight specific research priorities and subgroup structures that would lead to improved patient outcomes from the personalization of treatment decisions.ResultsWe graphically present the 3 measures to perform sensitivity analyses around the key drivers of value, in particular, the correlation between the individual treatment benefits across the available treatment options. We illustrate these 3 measures using a previously published decision model and discuss how they can direct research in personalized medicine.ConclusionWe discuss 3 measures that form the basis of a novel framework to prioritize research into novel personalized treatment strategies. Our novel framework ensures that research targets personalized treatment strategies that have high potential to improve patient outcomes and health system efficiency.HighlightsIt is important to undertake research prioritization before conducting any research that aims to discover novel methods (e.g., biomarkers) for personalizing treatment.The value of unexplained heterogeneity can highlight disease areas in which personalizing treatment can be valuable and determine key priorities within that area.These priorities can be determined under assumptions of the magnitude of the individual-level treatment effect, which we explore in sensitivity analyses.

Journal

Medical Decision Making – SAGE

Published: Jul 1, 2022

Keywords: precision medicine; personalized medicine; research prioritization; study design; simulation modeling; value of heterogeneity; value of information

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

References (62)

Abstract

Journal

Recommended Articles

There are no references for this article.

Our policy towards the use of cookies